Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.628
-0.032 (-1.94%)
Nov 21, 2024, 11:33 AM EST - Market open

Gain Therapeutics Revenue

In the year 2023, Gain Therapeutics had annual revenue of $55.18K, down -58.40%.

Revenue (ttm)
$55.18K
Revenue Growth
-58.40%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
41.57M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202355.18K-77.46K-58.40%
Dec 31, 2022132.64K-1.29K-0.96%
Dec 31, 2021133.93K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SCYNEXIS 8.57M
LAVA Therapeutics 7.40M
Serina Therapeutics 3.16M
OncoCyte 709.00K
Daxor 154.21K
Actinium Pharmaceuticals 81.00K
Revenue Rankings